[1]Karaman IlicM,Madzarac G,Kogler J,et al.Intraoperative volume restriction in esophageal cancer surgery:An exploratory randomized clinical trial[J].Croat Med J,2015,56(3):290-296.
[2]Firsova LD,Pichugina IM,Yanova OB,et al.Clinical and pathogenetic features of esophageal spasm[J].Ter Arkh,2015,87(4):36-40.
[3]Samaresena JB,Ahluwalia A,Tarnawski AS,et al.Expression of nerve growth factor,its TrkA receptor,and several neuropeptides in porcine esophagus. Implications for interactions between neural,vascular and epithelial components of the esophagus[J].J Physiol Pharmacol,2015,66(3):415-420.
[4]Kwon HC,Kim SH,Oh SY,et al.Clinicopathological significance of nuclear factor-kappa B,HIF-1 alpha,and vascular endothelial growth factor expression in stage III colorectal cancer[J].Cancer Sci,2010,101(6):1557-1561.
[5]Lamas MJ,Duran G.Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer[J].Pharmacogenomics,2011,12(3):433-442.
[6]Lu P,Yang X,Huang Y,et al.Antitumor activity of a combination of rAd2p53 adenoviral gene therapy and radiotherapy in esophageal carcinoma[J].Cell Biochem Biophys,2011,59(3):147-152.
[7]Ramkaran P,Phulukdaree A,Khan S,et al.Methylenetetrahydrofolate Reductase C677T polymorphism is associated with increased risk of coronary artery disease in young South African Indians[J].Gene,2015,18(6):1016-1119.
[8]Zhou CF,Ma T,Zhou DC,et al.Association of glutathione S-transferase pi (GSTP1) Ile105Val polymorphism with the risk of skin cancer:A meta-analysis[J].Arch Dermatol Res,2015,5(6).45-49.
[9]Lima MM Junior,Reis LO,Ferreira U,et al.Unraveling Brazilian Indian population prostate good health:Clinical,anthropometric and genetic features[J].Int Braz J Urol,2015,41(2):344-352.
[10]Lin CY,Wu CR,Chang SW,et al.Induction of the pi class of glutathione S-transferase by carnosic acid in rat Clone 9 cells via the p38/Nrf2 pathway[J].Food Funct,2015,10(6):1936-1943.
[11]Ellithy HN,Yousri S,Shahin GH.Relation between glutathione S-transferase genes (GSTM1,GSTT1,and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients[J].Hematology,2015,16(6):112-114.
[12]Stukova M,Hall MD,Tsotsoros SD,et al.Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients[J].J Inorg Biochem,.2015,149(8):145-148.
[13]Han B,Guo Z,Ma Y,et al.Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy[J].Int J Clin Exp Pathol,2015,8(4):4113-4119.
[14]Yuan ZJ,Zhou WW,Liu W,et al.Association of GSTP1 and RRM1 polymorphisms with the response and toxicity of gemcitabine-cisplatin combination chemotherapy in chinese patients with non-small cell lung cancer[J].Asian Pac J Cancer Prev,2015,16(10):4347-4351.
[15]Sawers L,Ferguson MJ,Ihrig BR,et al.Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines[J].Br J Cancer,2014,111(6):1150-1158.
[16]Qu CY,Zhou M,Chen YW,et al.Engineering of lipid prodrug-based,hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy[J].Int J Nanomedicine,2015,10(10):3911-3920.
[17]Kwon HC,Roh MS,Oh SY,et al.Prognostic value of expression of ERCC1,thymidylate synthase,and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer[J].Ann Oncol,2007,18(3):504-509.
[18]Yazbeck R,Lindsay R,Abbott CA,et al.Combined effects of muricid extract and 5-fluorouracil on intestinal toxicity in rats[J].Evid Based Complement Alternat Med,2015,10(6):170-178.
[19]Ramkaran P,Phulukdaree A,Khan S,et al.Methylenetetrahydrofolate Reductase C677T polymorphism is associated with increased risk of coronary artery disease in young South African Indians[J].Gene,2015 ,571(1):28-32.